SK bioscience, MSD and Hilleman Advance Ebola Vaccine with CEPI Funding
he collaboration will receive up to USD 30 million in CEPI funding to support development of MSD’s Zaire ebolavirus vaccine, with a focus on improving manufacturing efficiency, enhancing thermostability and expanding affordable vaccine access in low- and middle-income countries.
IDT Biologika | 23/01/2026 | By News Bureau
IDT Biologika Welcomes Federico Pollano as New Chief Commercial Officer
Federico Pollano has extensive experience in management positions at global CDMOs in the pharmaceutical and biotechnology industry.
IDT Biologika | 18/01/2025 | By Aishwarya | 431
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy